Abbott Ventricular Tachycardia PAS

Ki vehet részt

• Patient or legally acceptable representative or parent/guardian (as applicable) must provide written informed consent prior to any clinical investigation-related procedure
• Subjects who have recurrent, drug-refractory, sustained MMVT with non-ischemic structural heart disease and a clinical decision has been made to use FlexAbility SE for an ablation procedure prior to enrollment in the research study
• Refractory (i.e. not effective, not tolerated or not desired) to at least one Class I/III anti-arrhythmic medication for treatment of MMVT
• Implanted with a market released ICD or CRT-D prior to the Index Ablation Procedure
• Able and willing to comply with all study requirements

Ki nem vehet részt

• History of atriotomy or ventriculotomy within 4 weeks prior to the Index Ablation Procedure
• Active systemic infection
• Documented or known intracardiac thrombus or myxoma
• Patients with prosthetic valves as the catheter may damage the prosthesis
• Unable to receive heparin or an acceptable alternative to achieve adequate anticoagulation